Whatever the outcome of the countering lawsuits, it will be a challenging period for PBMs, given the FTC's actions on alleged ...

Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...

Express Scripts, Inc. (“Express Scripts”), one of the largest pharmacy benefit managers (PBMs) in the United States, ...

On September 20, the Federal Trade Commission (FTC) filed its first administrative complaint against PBMs under Chair Lina ...

Express Scripts, Inc. sued the Federal Trade Commission on Tuesday ... a subsidiary of The Cigna Group, is demanding the FTC retract a report it made in July 2024 that said the pharmacy benefit ...

The FTC may be gearing up to sue Express Scripts, CVS Caremark and OptumRx based on its investigation, Bloomberg News reported in July, citing a source familiar with the matter. Express Scripts ...

NEW YORK, Sept 17 (Reuters) - Pharmacy benefit manager Express Scripts sued the U.S. Federal Trade ... middlemen raise drug costs defamatory. The FTC said in the July report that market ...

including Express Scripts, that use their market power to overcharge patients. "The FTC has taken unconstitutional actions in ...

"Express Scripts sues FTC and demands drug pricing report retraction" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has ...

Cigna's Express Scripts, one of the country's largest pharmacy benefit managers, today sued the Federal Trade ... bringing drug costs down." Related: FTC staff objects to big PBMs' 'outsized ...

On Tuesday, the healthcare company’s PBM, Express Scripts, sued the Federal Trade Commission ... The lawsuit asks a federal judge to order the FTC to withdraw the report, and recuse FTC Chair ...

Express Scripts, one of the largest pharmacy benefit ... The lawsuit also alleged the FTC “followed prejudice and politics, not evidence or sound economics, and wrongly concluded that PBMs ...